Primary tumor location predicts poor clinical outcome with cetuximab in RAS wild-type metastatic colorectal cancer

BACKGROUND: In metastatic colorectal cancer, the location of the primary tumor has been suggested to have biological significance. In this study, we investigated whether primary tumor location affects cetuximab efficacy in patients with RAS wild-type metastatic colorectal cancer. METHODS: Genotyping...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Dalyong, Kim, Sun Young, Lee, Ji Sung, Hong, Yong Sang, Kim, Jeong Eun, Kim, Kyu-pyo, Kim, Jihun, Jang, Se Jin, Yoon, Young-Kwang, Kim, Tae Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701369/
https://www.ncbi.nlm.nih.gov/pubmed/29169325
http://dx.doi.org/10.1186/s12876-017-0694-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5701369/
https://www.ncbi.nlm.nih.gov/pubmed/29169325
http://dx.doi.org/10.1186/s12876-017-0694-6

Ejemplares similares